Acimethin
Acimethin is a medicine authorised by Swissmedic under authorisation number 48799. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 September 1988 and the authorisation is valid without a time limit. ATC code V03AB26 places the medicine in the group All other therapeutic products.
| Authorisation number | 48799 |
|---|---|
| Name | Acimethin |
| Full name | Acimethin, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AB26 |
| First authorisation | 19 September 1988 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Acimethin, Filmtabletten | B | 19 September 1988 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 19 | 50 | Tablette(n) | V03AB26 | 05.99.0. | B |
| 27 | 100 | Tablette(n) | V03AB26 | 05.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Acimethin authorised in Switzerland?
Yes. Acimethin is authorised by Swissmedic under authorisation number 48799, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Acimethin have?
Acimethin is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Acimethin?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.